7 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
"Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment" (PROTECT-HF)Arrhythmias, Cardiac, Bradycardia, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorderRecruitingNot applicable2026-07-22NCT05815745
Advancing Cath Lab Results With FFRangio Coronary Physiology AssessmentArterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorderActive, not recruitingNot applicable2026-03-10NCT05893498
Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancersdifferentiated thyroid carcinomaRecruitingNot applicable2026-03-05NCT05604963
PreOperative Endocrine Therapy for Individualised Care With AbemaciclibBreast Cancer FemaleActive, not recruitingPhase 32026-01-14NCT04584853
Oxford Pre-cancerous Lymphoproliferative Disorders StudyBlood Protein Disorders, Hemic and Lymphatic Diseases, Hypergammaglobulinemia, hematologic disorder, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, precancerous condition, smoldering plasma cell myelomaActive, not recruitingNot stated2025-02-03NCT04023747
Trial of Perioperative Endocrine Therapy - Individualising CareNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingPhase 32020-02-17NCT02338310
The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingPhase 32018-06-19NCT03562169